Answers are grounded in this paper and cite their sources.
Retrospective study shows subclavian vein catheterization is safe with lower thrombosis risk than femoral access in critically ill children, highlighting its viability as an alternative access route.
Background: Central venous catheterization (CVC) is an essential procedure in the management of critically ill pediatric patients. However, the optimal catheter insertion site remains controversial due to varying complication rates. This study aimed to evaluate the feasibility and safety of subclavian vein (SCV) catheterization compared to femoral vein (FV) and internal jugular vein (IJV) access in a pediatric intensive care setting.Methods: This retrospective study included all patients admitted to the pediatric intensive care unit (PICU) of a tertiary hospital over a one-year period (March 2022–March 2023) who underwent nontunneled central venous catheter placement.Results: Among 174 patients included (median age 29 months, 60.3% male), 52.9% had SCV, 23.6% FV, and 23.6% IJV catheterization. The overall CVC success rate was 99.4%. There was no statistically significant difference in mechanical complications, catheter-related bloodstream infections, or thrombosis between groups, however, thrombosis occurred most frequently in the FV group (12.2%). The median age in the SCV group was significantly lower than in the other groups (20 months; interquartile range, 10–63; P<0.001), while the presence of chronic diseases was significantly higher in this group (P=0.02). In multivariate logistic regression, catheter site was identified as the only independent predictor of thrombosis, with FV catheterization associated with increased risk (OR, 2.75; P=0.016).Conclusions: SCV catheterization appears to be a feasible and safe option for critically ill children, even in younger patients and in the presence of chronic comorbidities. Despite potential technical challenges, SCV access represents a viable alternative to IJV and may offer potential advantages over FV, particularly with regard to thrombosis risk.
No takes yet. Share an insight, caveat, or question.
Özel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: